[Federal Register Volume 89, Number 7 (Wednesday, January 10, 2024)]
[Notices]
[Page 1580]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-00290]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR-22-233: Time-Sensitive Opportunities for Health Research.
    Date: January 29, 2024.
    Time: 9:00 a.m. to 7:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Hoa Thi Vo, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 1002B2, Bethesda, MD 20892, (301) 594-0776, 
[email protected].

    Name of Committee: Integrative, Functional and Cognitive 
Neuroscience Integrated Review Group, Behavioral Neuroendocrinology, 
Neuroimmunology, Rhythms, and Sleep Study Section.
    Date: February 1-2, 2024.
    Time: 9:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Michael Selmanoff, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5164, MSC 7844 Bethesda, MD 
20892, 301-435-1119, [email protected].
    Name of Committee: Risk, Prevention and Health Behavior 
Integrated Review Group, Psychosocial Development, Risk and 
Prevention Study Section.
    Date: February 1-2, 2024.
    Time: 9:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Anna L Riley, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3114, MSC 7759 Bethesda, MD 20892, 301- 435-
2889, [email protected].

    Name of Committee: Bioengineering Sciences & Technologies 
Integrated Review Group; Drug and Biologic Therapeutic Delivery 
Study Section.
    Date: February 1-2, 2024.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications
    Place: National Institutes of Health Rockledge II 6701 Rockledge 
Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Janice Duy, Ph.D., Scientific Review Officer, 
Center for Scientific Review, 6701 Rockledge Drive, Bethesda, MD 
20892, 301-594-3139, [email protected].

    Name of Committee: Population Sciences and Epidemiology 
Integrated Review Group; Social Sciences and Population Studies A 
Study Section.
    Date: February 1-2, 2024.
    Time: 10:00 a.m. to 8:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Suzanne Ryan, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3139, MSC 7770 Bethesda, MD 20892, (301) 435-
1712, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: January 4, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-00290 Filed 1-9-24; 8:45 am]
BILLING CODE 4140-01-P